The US Supreme Court will hear arguments Monday on whether to allow private entities to patent genes they have isolated and identified, a decision that could have far-reaching implications for genetic research.
Genetics Apr 13, 2013 | 5 / 5 (2) | 0
(Medical Xpress)—On April 15, the Supreme Court will hear oral argument in Association for Molecular Pathology v. Myriad Genetics, a case that could answer the question, "Under what conditions, if any, ...
Genetics Apr 11, 2013 | 4.3 / 5 (6) | 16 |
(Medical Xpress)—Companies may be misusing the drug patenting system in order to gain control over high-cost drugs in Australia, research from the Melbourne Law School has found.
Medications Apr 10, 2013 | 5 / 5 (1) | 0 |
India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies ...
Medications Mar 31, 2013 | not rated yet | 0
(AP)—From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will ...
Medications Jan 04, 2013 | not rated yet | 0
Indian generics giant Cipla says it has scored a "landmark" court win in a patent challenge launched by Switzerland's Roche Holding over the Mumbai firm's version of a lung-cancer drug.
Medications Sep 08, 2012 | 5 / 5 (4) | 2
The US Senate Thursday passed legislation to drag the web of US patent laws into the Internet age and spur high-tech innovation, sending the measure to President Barack Obama to sign into law.
Health Sep 09, 2011 | not rated yet | 1
Supply of cheap, copycat drugs for the developing world could be badly threatened if Swiss firm Novartis wins a challenge to India's patent law, medical charity MSF said on Monday.
Medications Sep 05, 2011 | 5 / 5 (4) | 1